ID-CARE Team heads to Munich for ESCMID Global 2026

Later this week, ID-CARE Team Members will be joining over 16,000 infectious disease and microbiology specialists at for the annual conference of the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in Munich, Germany.

The conference, ESCMID Global, is one of the largest and the foremost congresses in the field of infection, bringing together >16,000 colleagues from all over the world for scientific education, networking and exchange. The comprehensive scientific programme is built by the ESCMID Global Programme Committee, an independent group of experts representing all disciplines related to clinical microbiology, infectious diseases, infection prevention and control and public health. This ensures that the programme is a combination that spans the entire range of topics in these fields, allowing every participant to have a comprehensive educational and networking experience.

Members of the ID-CARE team will be attending and presenting, with a total of 17 presentations, five of which are oral presentations. See below an overview of the presentations taking place, make sure you come by and say hello!

Oral Presentations

• Maria Diletta Pezzani, in Hall A1-5 at 11:00 on Saturday 18 April.

  Bridging Surveillance and Stewardship: The Emerging Resistance Index as a Compass for Reserve Antibiotic Use     

  D. Ortiz, J. Garlasco, K. Odoj, M.D. Pezzani, F. Arieti, M. Morra, E. Addis, M. Tebon, O. Awwad, A. Cassini, S. Harbarth, E. Presterl, G. Kahlmeter, A. Savoldi, E. Tacconelli

• Daniele Fasan, in Hall A1-5 at 11:36 on Saturday 18 April.

  MDR-GN screening to guide perioperative prophylaxis in colorectal surgery: a multicenter quasi-experimental study

  D. Fasan, E. Carrara, M. Tebon, M. Morra, D. Pezzani, M. Da Meda, V. Mengardo, M. Genna, S. Zerva, A.R. Andritsos, I.M. Fieraru, D. Costin, I. Salcedo-Leal, C. Díaz-López, A. Sonpar, J. Rodriguez Bano, P. Retamar, N. Zuabi-Garcia, W. Zingg, E. Tacconelli, and REVERSE Study Group

• Evelina Tacconelli, in Hall A3-1 at 11:30 on Saturday 18 April

  Diagnostic stewardship is an auxiliary to antimicrobial stewardship, but has no impact on quality of care

• Rebecca Scardellato, in Hall A3-1 at 11:00 on Sunday 19 April.

  The role of rectal swabs in driving empirical antibiotic therapy in febrile neutropenic patients: a quasi-experimental multi-centre study within the REVERSE project

  R. Scardellato, M. Morra, A.M. Azzini, M.C. Negulescu, A.M.J. Anghel, A. Araújo, M.T. Pérez-Rodríguez, G. Nadali, C. Tecchio, A. Sonpar, J.R. Baño, P. Retamar, N. Zuabi Garcia, C. Niculae, A. Hristea, W. Zingg, E. Tacconelli, E. Carrara, and REVERSE Study Group

• Evelina Tacconelli, in Hall ICM 5 at 11:00 on Tuesday 21 April

  The ESCMID blueprint for prevention: a deep dive into the new guidelines

ePoster Presentations

Saturday 18 April, 11:00

• Integrating antibiotic stewardship within a One Health framework: a pilot study on knowledge, attitude and practice questionnaire in companion animal veterinary medicine in Norther Italy

  F. Compostella, M. Domaschio, D. Fasan, F. Sbardellati, E. Tacconelli, E. Carrara

Sunday 19 April, 16:15

• The ECRAID Emerging Resistance Index by European region: assessing the index’s applicability in different epidemiological contexts

  J. Garlasco, F. Arieti, M. Morra, D. Ortiz, E. Addis, M. Tebon, O. Awwad, K. Odoj, M.D. Pezzani, A. Cassini, S. Harbarth, E. Presterl, G. Kahlmeter, A. Savoldi, E. Tacconelli

  
  

Monday 20 April, 11:00

• Integrating the ECRAID Emerging Resistance Index (ERI) into Antibiotic Policy for New Antibiotics Targeting Multidrug-Resistant Gram-Negative Bacteria: A Proof-of-Concept Analysis

  M.D. Pezzani, J. Garlasco, D. Ortiz, F. Arieti, M. Morra, K. Odoj, E. Addis, M. Tebon, O. Awwad, A. Cassini, S. Harbarth, E. Presterl, G. Kahlmeter, A. Savoldi, E. Tacconelli

Poster Presentations, Poster Hall B3, 12:00-13:30

Saturday 18 April

• Linking epidemiological surveillance and predictive modelling to update rabies post-exposure prophylaxis protocol

  C. Konishi de Toffoli, L. Lambertenghi, J. Garlasco, F. Marchiori, C. Postiglione, L. De Sabata Formenton, T. Patregnani, F. Lattanzi, E. Tacconelli

• FAIR-aligned, AI-assisted ontology for infectious disease studies to accelerate evidence generation for pandemic preparedness response

  A. Górska, M. Morra, A. Visentin, A. Nazeri, C. Fleming, J. Malzahn, E. Tacconelli

• Lessons from the European mpox outbreak: strengthening cohort research for future pandemic preparedness

  A. Visentin, A. Nazeri, A. Górska, C. Fleming, J. Malzahn, M. Mirandola, J.L. Peñalvo, V.C. Simensen, N. Langeland, Q. Gaday, Z.D. Pana, X. Lescure, A. Judd, E. Tacconelli, and the CCB Working Group on mpox 

• Clinical Outcomes of Implementing Bacterial and Viral Rapid Diagnostics Tests to Detect Bloodstream Infections: A Systematic Review and Metanalysis.

  A.G. Salvadori, M. Fezzi, A. Visentin, A. Leonardi, M. Morra, M. Mirandola, E. Gerola, L. Chamani-Tabriz, M. Paul, P.A. Grossi, M. Sanguinetti, B. Posteraro, E. Carrara, K. Thursky, E. Tacconelli

• Clinical Outcomes of Implementing Bacterial and Viral Rapid Diagnostics Tests to Detect Respiratory Tract Infections: A Systematic Review and Metanalysis.

  M. Fezzi, A.G. Salvadori, A. Visentin, A. Leonardi, M. Morra, M. Mirandola, E. Gerola, L. Chamani-Tabriz, M. Paul, P.A. Grossi, M. Sanguinetti, B. Posteraro, E. Carrara, E. Tacconelli

Sunday 19 April

• The REVERSE-antibiotic stewardship tool: multinational validation from vignettes to clinical practice

  A. Leonardi, M. Tebon, D. Fasan, E. Tacconelli, E. Carrara, Evaluators, and REVERSE Study Group

• Predicting early mortality in bacteraemia: cross-country validation of the BLOOMY-14 Day scores in Italy, Germany, and Finland

  M. Morra, F. Cioli Puviani, C.M.R. Conti, R. Scardellato, B.P. Gladstone, J. Rannikko, J. Tietäväinen, E. Piccinno, D. Girelli, A. Mazzariol, E. Tacconelli, A.M. Azzini

• Toward model informed precision dosing for Dalbavancin

  M. Morra, J.A. Roberts, C. Leven, E. Tacconelli, M. Gregorie

• Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: analysis of WHO’s global pharmacovigilance database, VigiBase®

  F. Luca, A. Savoldi et al